Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

World Journal of Gastroenterology

Volumn 21, Issue 17, 2015, Pages 5359-5371

  Rossen, Noortje G ^a   MacDonald, John K ^b   De Vries, Elisabeth M ^a   D'Haens, Geert R ^a   De Vos, Willem M ^c,d   Zoetendal, Erwin G ^d   Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF HELSINKI   (Finland)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Clostridium difficile infection; Fecal microbiota transplantation; Inflammatory bowel disease; Metabolic syndrome; Microbiota

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM INFECTION; COCHRANE LIBRARY; CONSTIPATION; CROHN DISEASE; DIARRHEA; DONOR; EMBASE; FECAL MICROBIOTA TRANSPLANTATION; FOLLOW UP; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HUMAN; ILEITIS; INFLAMMATORY BOWEL DISEASE; INSULIN SENSITIVITY; INTENTION TO TREAT ANALYSIS; IRRITABLE COLON; MEDLINE; METABOLIC SYNDROME X; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SAFETY; SENSITIVITY ANALYSIS; TREATMENT INDICATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; FECES; GASTROINTESTINAL DISEASES; INTESTINE; META ANALYSIS; MICROBIOLOGY; MICROFLORA; RISK FACTOR; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; MICROBIOTA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84928983066     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i17.5359     Document Type: Article

References (63)

1. Ge H. Zhou Hou Bei Ji Fang. Tianjin: Tianjin Science and Technology, 2000
2. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859 [PMID: 13592638 DOI: 10.1067/S0039-6060(03)00474-4]
3. Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211-215 [PMID: 6740251]
4. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; 1: 164 [PMID: 2563083 DOI: 10.1016/S0140-6736(89)91183-5]
5. Borody T, Wettstein A, Campbell J, Leis S, Torres M, Finlayson S, Nowak A. Fecal microbiota transplantation in ulcerative colitis: Review of 24 years experience. Am J Gastroenterol Conf 77th Annu Sci Meet Am Coll Gastroenterol 2012; 107: S665 [DOI: 10.1038/ajg.2012.275]
6. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150: 604 [PMID: 2783214]
7. Andrews PJ, Barnes P, Borody TJ. Chronic constipation reversed by restoration of bowel flora: A case and a hypothesis. Eur J Gastroenterol Hepatol 1992; 4: 245-247
8. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551-561 [PMID: 20716985 DOI: 10.1097/MCG.0b013e3181e5d06b]
9. Landy J, Omar Al-Hassi H, Ronde E, Mann E, Peake S, McLaughlin S, Perry-Woodford ZL, Ciclitira PJ, Nicholls RJ, Clark SK, Knight S, Hart AL. A prospective controlled pilot study of faecal microbiota transplantation for chronic refractory pouchitis. ECCO Conf Abstr 2013; P591
10. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916.e7 [PMID: 22728514 DOI: 10.1053/j.gastro.2012.06.031]
11. Borody TJ, Nowak A, Torres M, Campbell J, Finlayson S LS. Bacteriotherapy in chronic fatigue syndrome (CFS): a retrospective review. Am J Gastroenterol 2012; 107: 1481
12. Borody TJ, Campbell J, Torres M, Nowak A, Leis S. Reversal of idiopathic thrombocytopenic purpura with Fecal Microbiota Transplantation (FMT). Am J Gastroenterol 2011; 106: 941
13. Borody TJ, Leis S, Campbell J, Torres M, Nowak A, Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am J Gastroenterol 2011; 942
14. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-34 [PMID: 19631507]
15. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Version 510 (updated March 2011), Cochrane Collab 2011. Available from: URL: http://www.cochrane-handbook.org
16. Chambers D, Rodgers M, Woolacott N. Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies. J Clin Epidemiol 2009; 62: 1253-1260.e4 [PMID: 19349144 DOI: 10.1016/j.jclinepi.2008.12.010]
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560 [PMID: 12958120 DOI: 10.1136/bmj.327.7414.557]
18. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415 [PMID: 23323867 DOI: 10.1056/NEJMoa1205037]
19. Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, Alm EJ, Gevers D, Russell GH, Hohmann EL. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-1522 [PMID: 24762631]
20. Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficileassociated disease by donated stool transplanted via colonoscopy: a case series of patients. J Clin Gastroenterol 2010; 44: 562-566 [PMID: 20463588 DOI: 10.1097/MCG.0b013e3181dac035]
21. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 2010; 8: 471-473 [PMID: 20117243 DOI: 10.1016/j.cgh.2010.01.007]
22. Shiekh Sroujieh L, Hassan M, Zainah H, Alangaden G, Jeepalyam S, Morilla Holguin ME, Johnson L, Zervos M, Ramesh M. Intestinal Microbiota Transplantation (Fecal Transplantation) for Clostridium difficile Infection-A Single Center Experience. ID week 1223 2012
23. Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe 2013; 19: 22-26 [PMID: 23182843 DOI: 10.1016/j.anaerobe.2012.11.004]
24. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44: 567-570 [PMID: 20485184 DOI: 10.1097/MCG.0b013e3181dadb10]
25. Potakamuri Lakshmi N, Turnbough L, Maheshwari A, Kantsevoy S, Ofosu A, Thuluvath PJ. Effectiveness of Fecal Microbiota Transplantation for the treatment of recurrent Clostridium difficile infection: Community hospital experience. ACG Annu Sci Meet Abstr 2013; P933
26. Newton D. Fecal Biotherapy as treatment for recurrent Clostridium difficile infection in immunocompromised patients. ACG Annu Sci Meet Abstr 2013; P925
27. Neelakanta A, Moudgal V, Upadhyay N, Valenstein P, Gunaratnam NT. Successful Treatment of Refractory Clostridium difficile Infection(Cdi) With Intestinal Microbiota Transplant (IMT) in Two Patients With Inflammatory Bowel Disease (IBD) and Its Effects on IBD. Gastroenterology 2011; 142: S-395 [DOI: 10.1016/S0016-5085(12)61499-1]
28. Miller CB, Dellon E, Isaacs K, Gangarosa L. Fecal bacteriotherapy via colonoscopy as rescue therapy for refractory and recurrent clostridium difficile - Associated diarrhea. Am J Gastroenterol 2010; 105: S323
29. Mellow M. Colonoscopic fecal bacteriotherapy in the treatment of recurrent clostridium difficile infection-results and follow-up. Am J Gastroenterol 2010; 105: 121-150
30. Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppälä M, Mattila PS, Anttila VJ, Arkkila P. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-496 [PMID: 22155369 DOI: 10.1053/j.gastro.2011.11.037]
31. MacConnachie AA, Fox R, Kennedy DR, Seaton RA. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 2009; 102: 781-784 [PMID: 19726581 DOI: 10.1093/qjmed/hcp118]
32. Louie T, Cannon K, O'Grady H, Wu K, Ward L. Fecal microbiome transplantation (FMT) via oral fecal microbial capsules for recurrent Clostridium difficile infection (rCDI). ID week 2013
33. Khanna S, Kashyap PC, Rainey JF, Kammer PP, Loftus EV. Outcomes from Fecal Microbiota Trasplantation in adults with C. difficile Infection and Inflammatory Bowel Disease. ACG Annu Sci Meet Abstr 2013; 1657
34. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46: 145-149 [PMID: 22157239 DOI: 10.1097/MCG.0b013e318234570b]
35. Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal Transplantation via Retention Enema is Effective for Recurrent or Refractory Clostridium difficile-Associated Diarrhea. Gastroenterology 2010; 138: S207-S208 [DOI: 10.1016/S0016-5085(10)60939-0]
36. Jorup-Rönström C, Hakanson A, Sandell S, Edvinsson O, Midtvedt T, Persson AK, Norin E. Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scand J Gastroenterol 2012; 47: 548-552 [PMID: 22468996 DOI: 10.3109/0 0365521.2012.672587]
37. Ihunnah C, Khoruts A, Fischer M, Afzali A, Aroniadis, Barto A, Borody TJ, Brandt LJ, Giovanelli A, Gordon S, Hohmann E, Kao D, Kao J, McQuillen DP, Mellow M, Rank K, Arnab R, Schwartz M, Singh N, Stollman N, Surawicz C, Suskind D, Vindigni S, Youngster I, Kelly C. Fecal Microbiota Transplantation (FMT) for Treatment of Clostridium difficile Infection (CDI) in Immunocompromised Patients. ACG Annu Sci Meet Abstr 2013; S179-S180
38. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-767 [PMID: 22290405 DOI: 10.1038/ajg.2011.482]
39. Garborg K, Waagsbø B, Stallemo A, Matre J, Sundøy A. Results of faecal donor instillation therapy for recurrent Clostridium difficileassociated diarrhoea. Scand J Infect Dis 2010; 42: 857-861 [PMID: 20662620 DOI: 10.3109/00365548.2010.499541]
40. Fischer M. Fecal MIcrobiota Transplantation for recurrent Clostridium difficile in patients with prolonged immunosuppression. UEGW 2013; P922
41. Elopre L, Rodriguez M. Fecal microbiota therapy for recurrent Clostridium difficile infection in HIV-infected persons. Ann Intern Med 2013; 158: 779-780 [PMID: 23689775]
42. Byrne B, Ward L, Louie M, Louie T, Krulicki WA, Louie TJ. Home- Based Fecal Flora Infusion to Arrest Multiply-Recurrent Clostridium difficile Infection(CDI). ID week k-4201 abstract 2008. ID week 2008
43. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 1079-1087 [PMID: 22450732 DOI: 10.1038/ajg.2012.60]
44. Borody TJ, Wettstein A, Nowak S, Finlayson SL. Fecal Microbiota Transplantation (FMT) eradicated clostridium difficile infection (CDI) in inflammatory bowel disease (IBD). UEGW 2013
45. Bobo L. Fecal Microbial Transplantation: Highly Effective Treatment for Severe Clostridium difficile Infection. ID week 2013; 281-284 [DOI: 10.4135/9781412964623.n89]
46. Siddharth B, Serban R, Kemal NR, Casey K, Dunnigan K. Fecal Microbiota Transplant for recurrent Clostridium difficile infection at a teaching hospital in upstate New York our experience. ACG Annu Sci Meet Abstr 2013; P976
47. Aroniadis OC, Brandt LJ, Greenberg A, Borody TJ, Mellow M, Surawicz C, Cagle LA, Neshatian L. Long-Term Follow-up Study of Fecal Microbiota Transplantation (FMT) for Severe or Complicated Clostridium difficile Infection (CDI). Gastroenterology 2013; 144: S185 [DOI: 10.1016/S0016-5085(13)60656-3]
48. Arkkila PE, Uusitalo-Seppälä R, Lehtola L, Moilanen V, Ristikankare M, Mattila EJ. Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection. Gastroenterology 2010; 138: S-5 [DOI: 10.1016/S0016-5085(10)60023-6]
49. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-585 [PMID: 12594638 DOI: 10.1086/367657]
50. Bowden TA, Mansberger AR, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981; 47: 178-183 [PMID: 7224366]
51. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108: 1620-1630 [PMID: 24060759 DOI: 10.1038/ajg.2013.257]
52. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H, Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56: 597-601 [PMID: 23542823 DOI: 10.1097/MPG.0b013e318292fa0d]
53. Kump PK, Gröchenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, Deutschmann A, Wenzl HH, Petritsch W, Krejs GJ, Gorkiewicz G, Högenauer C. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013; 19: 2155-2165 [PMID: 23899544 DOI: 10.1097/MIB.0b013e31829ea325]
54. Kump PK, Gröchenig HP, Spindelböck W, Gorkiewicz G, Wenzl H, Petritsch W, Reicht G. Preliminary clinivcal results of repeatedly fecal microbiota transplantation (FMT) in chronic activ ulcerative colitis. UEGW 2013; OP187
55. Vermeire S, Joossens M, Verbeke K, Hildebrand F, Machiels K, Van den Broeck K, Van Assche G, Paul J. Rutgeerts, Jeroen Raes2 3. Pilot Study on the Safety and Efficacy of Faecal Microbiota Transplantation in Refractory Crohn. Gastroenterology 2012; 142: P7160, S-360
56. Greenberg A, Aroniadis O, Shelton C, Brandt LJ. Long-term followup study of fecal microbiota transplantation (FMT) for Inflammatory Bowel Disease (IBD). ACG Annu Sci Meet Abstr 2013; P1629
57. Pinn D, Aroniadis O, Brandt LJ. Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel synrome (IBS). ACG Annu Sci Meet Abstr 2013; P1688
58. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004; 38: 475-483 [PMID: 15220681]
59. Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract Res Clin Gastroenterol 2013; 27: 127-137 [PMID: 23768558 DOI: 10.1016/j.bpg.2013.03.003]
60. Kump PK, Gröchenig HP, Lackner S, Trajanovski S, Reicht G, Hoffmann, Wenzl HH, Petritsch W, Gorkiewicz G. Successful improvement of dysbiosis by fecal microbiota transplantation is not sufficient to induce clinical remission in chronic active ulcerative colitis. ECCO 2013; P364
61. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-47 [PMID: 12811208 DOI: 10.1097/00004836-200307000-00012]
62. Kelly C. Successful treatment of recurrent clostridium difficile infection with donor stool administered at colonoscopy: A case series. Am J Gastroenterol 2010; S135
63. Angelberger S, Lichtenberger C, Gratzer C, Papay P, Primas C, Eser A, Mikulits A, Dejaco C, Novacek G, Vogelsang H, Reinisch W. Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis (UC). J Crohn's Colitis 2012; 6: S159 [DOI: 10.1016/S1873-9946(12)60393-6]